These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 25655757)

  • 21. The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study.
    Salerno F; Borzio M; Pedicino C; Simonetti R; Rossini A; Boccia S; Cacciola I; Burroughs AK; Manini MA; La Mura V; Angeli P; Bernardi M; Dalla Gasperina D; Dionigi E; Dibenedetto C; Arghittu M;
    Liver Int; 2017 Jan; 37(1):71-79. PubMed ID: 27364035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ceftolozane/Tazobactam Plus Metronidazole for Complicated Intra-abdominal Infections in an Era of Multidrug Resistance: Results From a Randomized, Double-Blind, Phase 3 Trial (ASPECT-cIAI).
    Solomkin J; Hershberger E; Miller B; Popejoy M; Friedland I; Steenbergen J; Yoon M; Collins S; Yuan G; Barie PS; Eckmann C
    Clin Infect Dis; 2015 May; 60(10):1462-71. PubMed ID: 25670823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug-resistant bacterial infections in patients with liver cirrhosis in a tertiary referral hospital.
    Béjar-Serrano S; Del Pozo P; Fernández-de la Varga M; Benlloch S
    Gastroenterol Hepatol; 2019 Apr; 42(4):228-238. PubMed ID: 30342782
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Home intravenous antibiotic therapy using a programmable infusion pump.
    Williams DN; Gibson JA; Bosch D
    Arch Intern Med; 1989 May; 149(5):1157-60. PubMed ID: 2719507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Surveillance of healthcare associated infections, bacterial resistance and antibiotic consumption in high-complexity hospitals in Colombia, 2011].
    Villalobos AP; Barrero LI; Rivera SM; Ovalle MV; Valera D
    Biomedica; 2014 Apr; 34 Suppl 1():67-80. PubMed ID: 24968038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical efficacy of tigecycline used as monotherapy or in combination regimens for complicated infections with documented involvement of multiresistant bacteria.
    Heizmann WR; Löschmann PA; Eckmann C; von Eiff C; Bodmann KF; Petrik C
    Infection; 2015 Feb; 43(1):37-43. PubMed ID: 25367409
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Safety and efficacy of intravenous colistin (colistin methanesulphonate) for severe multidrug-resistant Gram-negative bacterial infections.
    Cheng CY; Sheng WH; Wang JT; Chen YC; Chang SC
    Int J Antimicrob Agents; 2010 Mar; 35(3):297-300. PubMed ID: 20045293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fosfomycin: efficacy against infections caused by multidrug-resistant bacteria.
    Dinh A; Salomon J; Bru JP; Bernard L
    Scand J Infect Dis; 2012 Mar; 44(3):182-9. PubMed ID: 22176655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization.
    Garcia-Vidal C; Viasus D; Roset A; Adamuz J; Verdaguer R; Dorca J; Gudiol F; Carratalà J
    Clin Microbiol Infect; 2011 Nov; 17(11):1659-65. PubMed ID: 21463391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous colistin sulphomethate sodium for therapy of infections due to multidrug-resistant gram-negative bacteria.
    Pintado V; San Miguel LG; Grill F; Mejía B; Cobo J; Fortún J; Martín-Dávila P; Moreno S
    J Infect; 2008 Mar; 56(3):185-90. PubMed ID: 18280570
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of daptomycin in outpatient parenteral antimicrobial therapy: a prospective and multicenter cohort study (DAPTODOM trial).
    Cervera C; Sanroma P; González-Ramallo V; García de la María C; Sanclemente G; Sopena N; Pajarón M; Segado A; Mirón M; Antón F; Basterretxea A; Cuende A; Miró JM;
    Infect Dis (Lond); 2017 Mar; 49(3):200-207. PubMed ID: 27820968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An audit of patients admitted for home intravenous therapy directly from the emergency department.
    Montalto M
    Int J Clin Pract; 1997 Oct; 51(7):433-7. PubMed ID: 9536581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Home intravenous antibiotic therapy of hepatic abscess: Safety, efficacy and predictive factor of hospital readmission].
    Pardos-Gea J; Pérez-López J; San José Laporte A; Vilardell Tarrés M
    Med Clin (Barc); 2010 Apr; 134(11):473-6. PubMed ID: 20202654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Self-administered outpatient parenteral antimicrobial therapy (S-OPAT) for infective endocarditis: a safe and effective model.
    Pajarón M; Fernández-Miera MF; Allende I; Arnaiz AM; Gutiérrez-Cuadra M; Cobo-Belaustegui M; Armiñanzas C; de Berrazueta JR; Fariñas MC; Sanroma P;
    Eur J Intern Med; 2015 Mar; 26(2):131-6. PubMed ID: 25596808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Home intravenous antibiotic treatment: a study in 515 patients].
    Mendoza-Ruiz de Zuazu H; Casas-Arrate J; Martínez-Martínez C; de la Maza I; Regalado de los Cobos J; Cía-Ruiz JM
    Enferm Infecc Microbiol Clin; 2005; 23(7):396-401. PubMed ID: 16159538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients.
    Falagas ME; Rafailidis PI; Ioannidou E; Alexiou VG; Matthaiou DK; Karageorgopoulos DE; Kapaskelis A; Nikita D; Michalopoulos A
    Int J Antimicrob Agents; 2010 Feb; 35(2):194-9. PubMed ID: 20006471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Determining the Risk of Sepsis Using Nurse-Compounded Elastomeric Pumps for Continuous Infusion in Outpatient Parenteral Antibiotic Therapy.
    Dobson PM; Loewenthal M; Harris L
    J Infus Nurs; 2017; 40(5):282-285. PubMed ID: 28885476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Favorable results with intravenous antimicrobial therapy outside the hospital].
    van den Broek PJ; Haerkens HM; van Weert NJ; Vermeij P
    Ned Tijdschr Geneeskd; 1997 Nov; 141(47):2297-301. PubMed ID: 9550815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.